These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8872129

  • 1. A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.
    Schenk JF, Glusa E, Radziwon P, Butti A, Markwardt F, Breddin HK.
    Haemostasis; 1996; 26(4):187-94. PubMed ID: 8872129
    [Abstract] [Full Text] [Related]

  • 2. A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding time.
    Schenk JF, Glusa E, Radziwon P, Butti A, Markwardt F, Breddin HK.
    Haemostasis; 1996; 26(3):140-9. PubMed ID: 8738588
    [Abstract] [Full Text] [Related]

  • 3. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P.
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [Abstract] [Full Text] [Related]

  • 4. Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.
    Sarich TC, Wolzt M, Eriksson UG, Mattsson C, Schmidt A, Elg S, Andersson M, Wollbratt M, Fager G, Gustafsson D.
    J Am Coll Cardiol; 2003 Feb 19; 41(4):557-64. PubMed ID: 12598065
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of a supersulfated low molecular weight heparin (IK-SSH) on different hemostatic parameters.
    Glusa E, Barthel W, Schenk J, Radziwon P, Butti A, Markwardt F, Breddin KH.
    Haemostasis; 1998 Feb 19; 28(1):45-56. PubMed ID: 9885370
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.
    Esslinger HU, Haas S, Maurer R, Lassmann A, Dübbers K, Müller-Peltzer H.
    Thromb Haemost; 1997 May 19; 77(5):911-9. PubMed ID: 9184402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1991 Apr 08; 65(4):355-9. PubMed ID: 2057916
    [Abstract] [Full Text] [Related]

  • 10. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P.
    Thromb Haemost; 1994 Aug 08; 72(2):227-31. PubMed ID: 7831657
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiplatelet and anticoagulant effects of "HN-11 500," a selective thromboxane receptor antagonist.
    Schenk JF, Radziwon P, Fellier H, Breddin HK.
    Thromb Res; 2001 Jul 15; 103(2):79-91. PubMed ID: 11457465
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 15; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons.
    Kotzé HF, Lamprecht S, Badenhorst PN.
    Blood; 1995 Jun 01; 85(11):3158-63. PubMed ID: 7756648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K, Breddin HK.
    Haemostasis; 1991 Jun 01; 21 Suppl 1():88-92. PubMed ID: 1894199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.